NEW YORK – German cellular analytics firm Evorion Biotechnologies said on Tuesday that it has formed a strategic partnership with Jüke Systemtechnik and closed a financing round for an undisclosed amount to support commercialization of Evorion's cellular analysis platform.
Münster-based Evorion said that new and existing investors, including Jüke, participated in the financing round, with Jüke becoming an Evorion shareholder.